Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
May 12, 2023 $18.14 $18.14 $17.26 $17.53 466 918
May 11, 2023 $18.29 $18.66 $17.42 $18.15 852 314
May 10, 2023 $18.00 $19.28 $17.99 $18.41 671 086
May 09, 2023 $15.68 $17.92 $15.60 $17.75 758 075
May 08, 2023 $16.40 $16.94 $15.48 $16.21 445 024
May 05, 2023 $16.57 $16.93 $16.21 $16.24 331 204
May 04, 2023 $16.02 $16.54 $15.72 $16.31 428 904
May 03, 2023 $15.46 $16.81 $15.39 $16.15 849 791
May 02, 2023 $16.07 $16.14 $15.06 $15.25 669 528
May 01, 2023 $15.90 $16.31 $15.59 $16.04 447 174
Apr 28, 2023 $15.76 $16.15 $15.43 $15.93 439 758
Apr 27, 2023 $15.87 $15.90 $15.32 $15.74 510 138
Apr 26, 2023 $15.72 $16.40 $15.44 $15.81 527 719
Apr 25, 2023 $15.97 $16.68 $15.62 $15.72 733 546
Apr 24, 2023 $16.72 $16.93 $15.70 $16.02 464 193
Apr 21, 2023 $16.01 $17.22 $15.96 $16.89 613 471
Apr 20, 2023 $15.87 $16.25 $15.61 $15.84 612 368
Apr 19, 2023 $15.66 $16.39 $15.60 $16.12 443 302
Apr 18, 2023 $15.84 $16.24 $15.56 $15.91 507 331
Apr 17, 2023 $15.24 $16.07 $15.01 $15.79 808 817
Apr 14, 2023 $15.67 $15.80 $14.72 $15.05 757 598
Apr 13, 2023 $14.49 $15.88 $14.20 $15.69 1 482 399
Apr 12, 2023 $14.50 $14.50 $13.55 $13.69 828 607
Apr 11, 2023 $13.75 $14.13 $13.61 $13.99 606 655
Apr 10, 2023 $13.54 $13.72 $13.31 $13.64 680 338
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT